Data for NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? (Study ST000257)
(Analysis AN000408)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18:0 Sphinganine-1P | NA | NA | NA | NA | 0.9407 | NA | NA | NA | NA | 1.0541 | NA | NA | NA | NA | 1.0052 |
| 18:1 Sphingosine | 0.2690 | NA | 2.3957 | 0.2262 | 0.0202 | 0.1337 | NA | 3.4509 | 0.2193 | 0.0279 | 0.6711 | NA | 4.3185 | 0.2402 | 0.0273 |
| 18:1 Sphingosine-1P | NA | NA | 0.2304 | NA | 1.4139 | NA | NA | 0.3876 | NA | 1.7488 | NA | NA | 0.4704 | NA | 1.7488 |
| C14 Ceramide | 0.1340 | 3.7502 | 0.3304 | 0.0413 | 0.0208 | 0.1686 | 5.2116 | 0.5175 | 0.0524 | 0.0146 | 0.1983 | 3.9774 | 0.5313 | 0.0416 | 0.0100 |
| C16 Ceramide | 0.2379 | 3.4362 | 0.5292 | 0.0315 | 0.0255 | 0.1505 | 5.0712 | 0.7353 | 0.0303 | 0.0163 | 0.2713 | 3.6362 | 0.7778 | 0.0360 | 0.0148 |
| C18:1 Ceramide | 0.0088 | 4.3325 | 0.0013 | 0.0093 | 0.0001 | 0.0024 | 6.1848 | 0.0012 | 0.0068 | 0.0000 | 0.0033 | 4.4394 | 0.0014 | 0.0086 | 0.0000 |
| C18 Ceramide | 0.0064 | 4.6044 | 0.0038 | 0.0242 | 0.0001 | 0.0019 | 5.4792 | 0.0042 | 0.0221 | 0.0001 | 0.0029 | 4.8177 | 0.0052 | 0.0278 | 0.0001 |
| C18 dihydroceramide | 0.0298 | 5.0263 | 0.0044 | 0.0245 | 0.0065 | 0.0133 | 5.0042 | 0.0116 | 0.0298 | 0.0015 | 0.0148 | 4.7954 | 0.0089 | 0.0276 | 0.0013 |
| C20 Ceramide | 0.0346 | 4.5576 | 0.2399 | 0.0040 | 0.0053 | 0.0228 | 5.4434 | 0.1047 | 0.0045 | 0.0019 | 0.0265 | 4.3949 | 0.1531 | 0.0047 | 0.0023 |
| C24 Ceramide | 0.1156 | 2.5427 | 1.8064 | 0.0366 | 0.0355 | 0.0706 | 3.2433 | 2.0042 | 0.0440 | 0.0134 | 0.2775 | 2.3712 | 2.3567 | 0.0651 | 0.0172 |
| C24 dihydroceramide | 0.0759 | NA | 2.3725 | 0.0291 | 0.2793 | 0.0653 | NA | 3.3711 | 0.0326 | NA | 0.1546 | NA | 3.1059 | 0.0332 | NA |
Factors:
| F1 | Treatment:HFD | Tissue Type:Adipose |
| F2 | Treatment:HFD | Tissue Type:Hypothalmus |
| F3 | Treatment:HFD | Tissue Type:Liver |
| F4 | Treatment:HFD | Tissue Type:Muscle |
| F5 | Treatment:HFD | Tissue Type:Plasma |
| F6 | Treatment:LFD | Tissue Type:Adipose |
| F7 | Treatment:LFD | Tissue Type:Hypothalmus |
| F8 | Treatment:LFD | Tissue Type:Liver |
| F9 | Treatment:LFD | Tissue Type:Muscle |
| F10 | Treatment:LFD | Tissue Type:Plasma |
| F11 | Treatment:SW | Tissue Type:Adipose |
| F12 | Treatment:SW | Tissue Type:Hypothalmus |
| F13 | Treatment:SW | Tissue Type:Liver |
| F14 | Treatment:SW | Tissue Type:Muscle |
| F15 | Treatment:SW | Tissue Type:Plasma |
